Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.

× No keyword cloud information.

16 in total

Review 1. Practical considerations for planning a therapeutic apheresis procedure.

Authors: Suresh G Shelat
Journal: Am J Med Date: 2010-06-11 Impact factor: 4.965

Review 2. The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.

Authors: Rory M Shallis; Prajwal C Boddu; Jan Philipp Bewersdorf; Amer M Zeidan
Journal: Blood Rev Date: 2019-11-08 Impact factor: 8.250

3. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.

Authors: Xinyu Nan; Qian Qin; Cesar Gentille; Joe Ensor; Christopher Leveque; Sai R Pingali; Alexandria T Phan; Lawrence Rice; Swaminathan Iyer
Journal: Leuk Lymphoma Date: 2017-01-31

4. Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States.

Authors: Vijaya Raj Bhatt; Valerie Shostrom; Krishna Gundabolu; James O Armitage
Journal: Blood Adv Date: 2018-06-12

Review 5. Hyperleukocytosis, leukostasis and leukapheresis: practice management.

Authors: Chezi Ganzel; Joanne Becker; Paul D Mintz; Hillard M Lazarus; Jacob M Rowe
Journal: Blood Rev Date: 2012-02-23 Impact factor: 8.250

Review 6. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.

Authors: Rory M Shallis; Rong Wang; Amy Davidoff; Xiaomei Ma; Amer M Zeidan
Journal: Blood Rev Date: 2019-04-29 Impact factor: 8.250

Review 7. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors: Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal: Blood Date: 2016-11-28 Impact factor: 22.113

8. Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.

Authors: Amer M Zeidan; Nikolai A Podoltsev; Xiaoyi Wang; Jan Philipp Bewersdorf; Rory M Shallis; Scott F Huntington; Steven D Gore; Amy J Davidoff; Xiaomei Ma; Rong Wang
Journal: Cancer Date: 2019-09-04 Impact factor: 6.860

9. How I treat hyperleukocytosis in acute myeloid leukemia.

Authors: Christoph Röllig; Gerhard Ehninger
Journal: Blood Date: 2015-03-16 Impact factor: 22.113

10. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.

Authors: Min Hyuk Choi; Yeon Hwa Choe; Yongjung Park; Hyunjin Nah; Sinyoung Kim; Seok Hoon Jeong; Hyun Ok Kim
Journal: Transfusion Date: 2017-09-28 Impact factor: 3.157

2 in total

1. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.

Authors: Ikhwan Rinaldi; Resti Mulya Sari; Vanya Utami Tedhy; Kevin Winston
Journal: J Blood Med Date: 2021-07-14

Review 2. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

Authors: Jan Philipp Bewersdorf; Amer M Zeidan
Journal: Cells Date: 2020-10-17 Impact factor: 6.600

2 in total